JCO Oncology Practice : Impact Factor & More
eISSN: 2688-1535pISSN: 2688-1527
Share this on:
Key Metrics
CiteScore 
4.3
H-Index
70
Impact Factor
< 5
SJR
Q1Oncology
SNIP
1.25
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on JCO Oncology Practice
JCO Oncology Practice Journal Specifications
Indexed in the following public directories
Web of Science 
SJR
| Overview | |
| Publisher | LIPPINCOTT WILLIAMS & WILKINS |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 2020 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in JCO Oncology Practice ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in JCO Oncology Practice
Provider Follow-Up and Adherence to Imaging Surveillance Recommendations for Lung Cancer Survivors in a Nationwide Health Care System.
- 24 Apr 2026
- JCO oncology practice
Donor Selection in the Post-Transplant Cyclophosphamide Era: Do the Little Things Matter?
- 24 Apr 2026
- JCO oncology practice
Efficacy and Safety of 177Lu-PSMA-617 in Elderly Patients With Metastatic Castration-Resistant Prostate Cancer.
- 24 Apr 2026
- JCO oncology practice
Implementation of a Model Program at an Independent Community Oncology Practice for the Outpatient Administration of B-Cell Maturation Antigen-Directed Bispecific Antibody Step-Up Doses.
- 23 Apr 2026
- JCO oncology practice
Toward Sustainable Hematology/Oncology Fellowship Training Through Career-Aligned Specialization.
- 23 Apr 2026
- JCO oncology practice
Insurance Disparity in Novel Hormonal Therapy Initiation in Patients With Metastatic Hormone-Sensitive Prostate Cancer: Medicare Advantage Versus Traditional Medicare.
- 23 Apr 2026
- JCO oncology practice
Provider Follow-Up and Adherence to Imaging Surveillance Recommendations for Lung Cancer Survivors in a Nationwide Health Care System.
- 24 Apr 2026
- JCO oncology practice
Donor Selection in the Post-Transplant Cyclophosphamide Era: Do the Little Things Matter?
- 24 Apr 2026
- JCO oncology practice
Efficacy and Safety of 177Lu-PSMA-617 in Elderly Patients With Metastatic Castration-Resistant Prostate Cancer.
- 24 Apr 2026
- JCO oncology practice
Implementation of a Model Program at an Independent Community Oncology Practice for the Outpatient Administration of B-Cell Maturation Antigen-Directed Bispecific Antibody Step-Up Doses.
- 23 Apr 2026
- JCO oncology practice
Toward Sustainable Hematology/Oncology Fellowship Training Through Career-Aligned Specialization.
- 23 Apr 2026
- JCO oncology practice
Insurance Disparity in Novel Hormonal Therapy Initiation in Patients With Metastatic Hormone-Sensitive Prostate Cancer: Medicare Advantage Versus Traditional Medicare.
- 23 Apr 2026
- JCO oncology practice
FAQs on JCO Oncology Practice
How long has JCO Oncology Practice been actively publishing? 
What is the publishing frequency of JCO Oncology Practice?
How many articles did JCO Oncology Practice publish last year?
What is the eISSN & pISSN for JCO Oncology Practice?
What is Citescore for JCO Oncology Practice?
What is the H Index for JCO Oncology Practice ?
What is SNIP score for JCO Oncology Practice?
What is the SJR for JCO Oncology Practice?
Who is the publisher of JCO Oncology Practice?
